Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis’s heart failure drug Entresto presents mixed trial results

pharmaceutical-technologySeptember 04, 2019

Tag: Novartis , Heart , Entresto

PharmaSources Customer Service